Table 2.
Summary of SHOW results for all PFAS analytes
| Analyte | Abbreviation | CAS-RNb | Detection Limit | # positive SHOW results | % positive results | Weighted Geometric Mean | Min result | Max Result |
|---|---|---|---|---|---|---|---|---|
| Perfluoro-n-butanesulfonic acid | PFBS | 375-73-5 | 0.022 | 78 | 12.8926 | 0.0708 | 0.022 | 0.158 |
| Perfluoropentanesulfonic acid | PFPeS | 2706-91-4 | 0.015 | 351 | 58.0165 | 0.074 | 0.015 | 0.523 |
| Perfluoro-n-hexanesulfonic acid | PFHxS | 355-46-4 | 0.028 | 599 | 99.0083 | 1.138 | 0.033 | 30 |
| Perfluoro-n-heptanesulfonic acid | PFHpS | 375-92-8 | 0.027 | 583 | 96.3636 | 0.168 | 0.027 | 2.58 |
| Perfluoro-n-octanesulfonic acid | PFOS | 1763-23-1 | 0.036 | 602 | 99.5041 | 4.513 | 0.056 | 32.9 |
| Perfluorononanesulfonic acid | PFNS | 68259-12-1 | 0.018 | 1 | 0.16529 | 0.071 | 0.021 | 0.021 |
| Perfluoro-n-decanesulfonic acid | PFDS | 335-77-3 | 0.049 | 16 | 2.64463 | 0.071 | 0.05 | 0.188 |
| Perfluorooctanesulfonamide-methyl | FOSA | 754-91-6 | 0.029 | 1 | 0.16529 | 0.071 | 0.055 | 0.055 |
| perfluorooctanesulfonamide-ethyl | NMeFOSA | 31506-32-8 | 0.246 | 0 | 0 | N/A | N/A | N/A |
| perfluorooctanesulfonamide-methyl | NEtFOSA | 4151-50-2 | 0.064 | 3 | 0.5 | 0.071 | 0.085 | 0.102 |
| perfluorooctanesulfonamido acetic acid-ethyl | NMeFOSAA | 2355-31-9 | 0.145 | 294 | 48.6 | 0.137 | 0.147 | 2.8 |
| perfluorooctanesulfonamido acetic acid-Methyl | NEtFOSAA | 2991-50-6 | 0.184 | 13 | 2.15 | 0.073 | 0.195 | 2.02 |
| perfluorooctanesulfonamido ethanol | N-MeFOSE | 24448-09-7 | 0.099 | 1 | 0.17 | 0.071 | 0.128 | 0.128 |
| perfluorooctanesulfonamido ethanol | N-EtFOSE | 1691-99-2 | 0.139 | 0 | 0 | N/A | N/A | N/A |
| 4:2 Fluorotelomer sulfonic acid | 4:2 FTSA | 757124-72-4 | 0.067 | 50 | 8.26 | 0.072 | 0.066 | 0.151 |
| 6:2 Fluorotelomer sulfonic acid | 6:2 FTSA | 27619-97-2 | 0.149 | 0 | 0 | N/A | N/A | N/A |
| 8:2 Fluorotelomer sulfonic acid | 8:2 FTSA | 39108-34-4 | 0.101 | 26 | 4.3 | 0.072 | 0.102 | 0.227 |
| 10:2 Fluorotelomer sulfonic acid | 10:2 FTSA | 120226-60-0 | 0.081 | 33 | 5.45 | 0.071 | 0.082 | 0.122 |
| Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid | 9Cl-PF3ONS | 756426-58-1 | 0.009 | 252 | 41.65 | 0.071 | 0.009 | 0.293 |
| Perfluoro-n-butanoic acid | PFBA | 375-22-4 | 0.039 | 173 | 28.6 | 0.074 | 0.039 | 0.546 |
| Perfluoro-n-pentanoic acid | PFPeA | 2706-90-3 | 0.015 | 39 | 6.45 | 0.072 | 0.016 | 1.11 |
| Perfluoro-n-hexanoic acid | PFHxA | 307-24-4 | 0.043 | 2 | 0.33 | 0.071 | 0.046 | 0.071 |
| Perfluoro-n-heptanoic acid | PFHpA | 375-85-9 | 0.031 | 352 | 58.18 | 0.075 | 0.031 | 2.85 |
| Perfluoro-n-octanoic acid | PFOA | 335-67-1 | 0.025 | 603 | 99.67 | 1.196 | 0.038 | 19.1 |
| Perfluoro-n-nonanoic acid | PFNA | 375-95-1 | 0.021 | 601 | 99.34 | 0.452 | 0.022 | 12 |
| Perfluoro-n-decanoic acid | PFDA | 335-76-2 | 0.024 | 598 | 98.84 | 0.142 | 0.024 | 4.51 |
| Perfluoro-n-undecanoic acid | PFUnDA | 2058-94-8 | 0.042 | 460 | 76.03 | 0.094 | 0.042 | 1.36 |
| Perfluoro-n-dodecanoic acid | PFDoA | 307-55-1 | 0.053 | 23 | 3.8 | 0.071 | 0.057 | 0.295 |
| Perfluoro-n-tridecanoic acid | PFTriA | 72629-94-8 | 0.391 | 0 | 0 | N/A | N/A | N/A |
| Perfluoro-n-tetradecanoic acid | PFTeA | 376-06-7 | 0.032 | 2 | 0.33 | 0.071 | 0.035 | 0.041 |
| Perfluoro-n-hexadecanoic acid | PFHxDA | 67905-19-5 | 0.085 | 1 | 0.17 | 0.071 | 0.097 | 0.097 |
| Perfluoro-n-octadecanoic acid | PFODA | 16517-11-6 | 0.164 | 0 | 0 | N/A | N/A | N/A |
| 4,8-Dioxa-3Hperfluorononanoic acid | DONA | 919005-14-4 | 0.012 | 0 | 0 | N/A | N/A | N/A |
| 11-chloroeicosafluoro-3-oxaundecane-1-sulfonic acid | 11Cl-PF3OUdS | 763051-92-9 | 0.011 | 2 | 0.33 | 0.071 | 0.13 | 0.14 |
| 6:2 di-subs. polyfluoroalkyl phosphate. | 6:2 diPAP | 57677-95-9 | 0.077 | 23 | 3.8 | 0.073 | 0.078 | 0.451 |
| 8:2 di-subs. polyfluoroalkyl phosphate. | 8:2 diPAP | 678-41-1 | 0.134 | 3 | 0.5 | 0.071 | 0.254 | 0.296 |
| Perfluoro-2-methoxypropanoic acid. | PFMPA | 377-73-1 | 0.019 | 0 | 0 | N/A | N/A | N/A |
| Perfluoro-2-methoxybutanoic acid. | PFMBA | 863090-89-5 | 0.017 | 0 | 0 | N/A | N/A | N/A |
Highlighted rows indicate inclusion in both SHOW and NHANES analyses. Compounds with percentages of positive results less than 15% in SHOW were not included in comparisons as we are unable to draw reliable conclusions